+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Treatment of HIV infection: the antiretroviral nucleoside analogues. Nucleoside analogues: adverse effects



Treatment of HIV infection: the antiretroviral nucleoside analogues. Nucleoside analogues: adverse effects



Hospital Practice 27(Suppl. 2): 26-36



The three approved nucleoside analogues are fairly well tolerated, and only a few patients have to discontinue therapy permanently. However, because clinical experience is limited, especially with ddI and ddC, delayed toxicities are likely to emerge over time. In addition, physicians should be vigilant for overlapping toxicities from combination therapy with these and other medications.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 041848596

Download citation: RISBibTeXText

PMID: 1324255


Related references

Treatment of HIV infection: the antiretroviral nucleoside analogues. Nucleoside analogues: combination therapy. Hospital Practice 27(Suppl. 2): 14-25, 1992

Treatment of HIV infection: the antiretroviral nucleoside analogues. Nucleoside analogues: monotherapy. Hospital Practice 27(Suppl. 2): 5-13, 1992

Treatment of HIV infection: the antiretroviral nucleoside analogues. Introduction. Hospital Practice 27(Suppl. 2): 3-4, 1992

Favorable interaction of beta-L(-) nucleoside analogues with clinically approved anti-HIV nucleoside analogues for the treatment of human immunodeficiency virus. Biochemical Pharmacology 51(6): 731-736, 1996

Bystander effect of purine nucleoside analogues in HSV-1tk suicide gene therapy is superior to that of pyrimidine nucleoside analogues. Gene Therapy 6(2): 162-170, 1999

Nucleoside analogues 9. seco nucleoside analogues of some 5 fluorouracil nitrosourea molecular combinations having uracil as base synthesis and anti tumor activity. Anti Cancer Drug Design 4(3): 191-208, 1989

Conformationally locked nucleoside analogues. Synthesis of dideoxycarbocyclic nucleoside analogues structurally related to neplanocin C. Journal of Medicinal Chemistry 37(20): 3389-3399, 1994

Treatment of HIV infection in clinical practice. Wide-range genotypic resistance to all nucleoside analogues and protease inhibitors, and severe intolerance to all non-nucleoside inhibitors of inverse transcriptase. Recenti Progressi in Medicina 94(12): 560-561, 2003

HIV nucleoside analogues: new adverse effects on mitochondria?. Lancet 354(9184): 1046-1047, 1999

Treatment of schistosomiasis by purine nucleoside analogues in combination with nucleoside transport inhibitors. Biochemical Pharmacology 36(22): 3815-3822, 1987

In vitro and in ovo effects of various nucleoside and non-nucleoside analogues on influenza A and B virus replication. Antiviral Research 20(Suppl. 1): 152, 1993

Adverse and beneficial immunological effects of purine nucleoside analogues. Hematology and Cell Therapy 38(Suppl. 2): S75-S81, 1996

Studies on yeast nucleoside triphosphate nucleoside diphosphate transphosphorylase nucleoside diphosphokinase iv. steady state kinetic properties with thymidine nucleotides including 3' azido 3' deoxythymidine analogues. Enzyme 45(1-2): 1-13, 1991

Acetyl-carnitine deficiency in AIDS patients with neurotoxicity on treatment with antiretroviral nucleoside analogues. Aids 11(2): 185-190, 1997

Effect of human concentration nucleoside transporters 1 and multi-drug resistance protein 4 gene polymorphism on response of chronic hepatitis B to nucleoside analogues treatment. Sichuan Da Xue Xue Bao. Yi Xue Ban 45(6): 950-955, 2014